OverviewChartNewsTraderScreen

DZ Bank Knock-Out QIA/  DE000DJ87H47  /

EUWAX
2024-09-26  8:04:50 AM Chg.+0.030 Bid4:52:16 PM Ask4:52:16 PM Underlying Strike price Expiration date Option type
0.320EUR +10.34% 0.300
Bid Size: 55,000		 0.310
Ask Size: 55,000		 QIAGEN NV 42.993 EUR 2078-12-31 Put
GlobeNewswire 08-28 QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in c...
TeleTrader 08-26 Europe closes mixed amid Middle East crisis
GlobeNewswire 07-31 QIAGEN delivers solid performance and exceeds outlook for Q2 2024
GlobeNewswire 07-31 Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
GlobeNewswire 07-08 QIAGEN to enhance the identification of human remains of Indigenous people and African Americans
GlobeNewswire 07-02 QIAGEN N.V. to release results for Q2 2024 and hold webcast
GlobeNewswire 06-27 QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis in...
GlobeNewswire 06-17 QIAGEN announces 2028 strategy for solid profitable growth
GlobeNewswire 06-13 QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput N...
GlobeNewswire 06-12 QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to su...
GlobeNewswire 06-11 QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious dis...
GlobeNewswire 06-06 QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition per...
GlobeNewswire 06-05 QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of it...
GlobeNewswire 06-03 QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improv...
GlobeNewswire 05-30 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 05-30 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 05-29 QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...
GlobeNewswire 05-22 deepull appoints Didier Deltort to its Board of Directors
GlobeNewswire 05-14 QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire 05-13 QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire 05-07 QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire 05-07 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 05-07 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 05-02 QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire 04-29 QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance